AlphaStreet Newsdesk powered by AlphaStreet Intelligence
UnitedHealth Group surged 8.1% Tuesday to $304.20 after two Wall Street firms raised their price targets on the healthcare giant, signaling renewed confidence in the stock’s upside. The rally came on volume of 8.0M shares as Bernstein and Raymond James both issued bullish calls on the managed care leader.
Bernstein lifted its price target from $405 to $411 while maintaining an Outperform rating, while Raymond James reiterated its Outperform stance with a $330 target. The average new price target across both firms stands at $370, representing potential upside from current levels. The target adjustments reflect what analysts see as continued strength in UnitedHealth’s diversified business model spanning insurance operations and its Optum health services division.
The move adds momentum to a stock that commands a $276.1B market capitalization, cementing UnitedHealth’s position as one of the largest players in the Healthcare Plans sector. Tuesday’s volume reflects heightened investor interest following the analyst actions, as traders repriced shares based on the updated Wall Street outlooks. The twin upgrades suggest growing analyst conviction that the company’s scale advantages and integrated care model position it well in the current environment.
The analyst support comes as UnitedHealth continues to navigate a complex landscape for managed care operators. With operations spanning both insurance coverage and healthcare delivery through Optum, the company’s diversified revenue streams have historically provided some insulation from sector-specific headwinds. The Outperform ratings from both firms indicate expectations that this strategic positioning will continue to drive shareholder value.
This content is for informational purposes only and should not be considered investment advice. AlphaStreet Intelligence analyzes financial data using AI to deliver fast and accurate market information. Human editors verify content.